Abstract
Interferon-gamma (IFN-gamma) and interleukin-1 (IL-1) play an important role in the modulation of acute and chronic airway inflammation. Both IFN-gamma and IL-1 are known to increase the release of arachidonic acid (AA) from airway epithelial cells, suggesting that AA metabolites may mediate the cytokine-induced inflammation. This study was designed to examine the direct effect of IFN-gamma and IL-alpha on the phosphorylation of 85-kDa cytosolic phospholipase A(2) (cPLA(2)) and AA release in primary normal human bronchial epithelial (NHBE) cells. Treatment with IFN-gamma and IL-1alpha for 15 min induced a rapid increase of AA release from NHBE cells, which was blocked by the cPLA(2) inhibitor MAFP (p<0.05) but not by the sPLA(2) inhibitor LY311727 or iPLA(2) inhibitor HELSS. Immunoprecipitation and Western blot analysis showed that both IFN-gamma and IL-1alpha induced a rapid phosphorylation of cPLA(2). The IFN-gamma and IL-1alpha-induced cPLA(2) phosphorylation and AA release in the NHBE cells were inhibited by the p38 MAP kinase (MAPK) inhibitor SB203580, p42/44 MAPK inhibitor PD98059 and protein kinase C (PKC) inhibitor bisindolylmaleimide I. These results demonstrate the involvement of p38 and p42/44 MAPKs as well as PKC in the IFN-gamma and IL-1alpha-induced cPLA(2) phosphorylation and AA release in human airway epithelial cells.
MeSH terms
-
Arachidonic Acid / metabolism
-
Arachidonic Acids / pharmacology
-
Bronchi / cytology
-
Bronchi / drug effects
-
Bronchi / metabolism
-
Cells, Cultured
-
Cytosol / drug effects
-
Cytosol / metabolism
-
Enzyme Activation
-
Enzyme Inhibitors / pharmacology
-
Epithelial Cells / drug effects
-
Epithelial Cells / metabolism
-
Flavonoids / pharmacology
-
Humans
-
Imidazoles / pharmacology
-
Interferon-gamma / pharmacology*
-
Interleukin-1 / pharmacology*
-
Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase 1 / metabolism*
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinases / metabolism*
-
Naphthalenes / pharmacology
-
Organophosphonates / pharmacology
-
Phospholipases A / antagonists & inhibitors
-
Phospholipases A / drug effects
-
Phospholipases A / metabolism*
-
Phosphorylation
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C / drug effects
-
Protein Kinase C / metabolism*
-
Pyridines / pharmacology
-
Pyrones / pharmacology
-
p38 Mitogen-Activated Protein Kinases
Substances
-
Arachidonic Acids
-
Enzyme Inhibitors
-
Flavonoids
-
Imidazoles
-
Interleukin-1
-
Naphthalenes
-
Organophosphonates
-
Pyridines
-
Pyrones
-
methyl arachidonylfluorophosphonate
-
Arachidonic Acid
-
Interferon-gamma
-
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one
-
Protein Kinase C
-
Mitogen-Activated Protein Kinase 1
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases
-
Phospholipases A
-
SB 203580
-
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one